English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Sep 27, 2023

Dr. Peter Lee: 'this moment marks a true phase change where emerging capabilities can help health care organizations address some of their most pressing challenges'
+ Pharmaceuticals
Patient Daily | Sep 24, 2023

Trust for America's Health: 'It's critical to recognize that obesity is a multifactored disease involving much more than individual behavior'
+ Pharmaceuticals
Patient Daily | Sep 24, 2023

ARS Pharma CEO: 'We are deeply disappointed that this action further delays the availability of 'neffy' for the millions of people who are at risk of a potentially life-threatening severe allergic...
+ Pharmaceuticals
Patient Daily Report | Jul 18, 2023

Kidneys for Communities: 'The Kidneys for First Responders initiative connects those who want to support firefighters, EMTs and police officers by facilitating the living kidney donation'
+ Pharmaceuticals
Patient Daily Report | Jul 18, 2023

BioArctic CEO: FDA approval of Leqembi 'is a paradigm-shifting step in the fight against Alzheimer's disease'
+ Pharmaceuticals
Patient Daily Report | Jul 1, 2023

Akili CEO: 'We're thrilled to make EndeavorOTC available to adults who can benefit'
+ Pharmaceuticals
Patient Daily Report | Jun 28, 2023

Dr. Carolyn Bramante: Study shows 'significant impact' of metformin for COVID patients
+ Pharmaceuticals
Patient Daily Report | Jun 14, 2023

Scottsdale balloon dilation physician: 'I have personally performed over 2,000 in-office balloon sinuplasties'

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes